Ben, your expectations that mainstream media will report on this thing in any significant way just because we get EPA approval is wishful thinking. The only time they may possibly show some interest is after ASure proves itself in the marketplace.
All they could report on is the company PR stuff that is an embarrassing mixture of failed sales projections, no independent verification of claims, supposed hospital trials never reported on, a bed bug initiative that has gone silent, etc, etc, etc.
Major media simply won't put its reputation on the line to tout this machine and company claims before it's a proven success, no matter how promising it is.
That said, they may very well get some badly needed publicity where it really matters, in trade publications of the targeted markets.
These publications jump all over promising emerging technologies, especially if they look to them to become advertisers... which is exactly where Medizone should but all it's energies.
Every attempt to promote the stock to investors has been an expensive and dismal failure.